Physician profile
Maneka Kaul
NPI 1174522148
$876.27
in general payments reported to CMS, 2019-2025
10 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $36.63 · 2021: $47.45 · 2024: $253 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $294.64 | 2019 | |
| Inspire Medical Systems, INC. | $262.62 | 2024-2025 | Inspire |
| Eisai INC. | $95.25 | 2024 | |
| Alexion Pharmaceuticals, INC. | $79.60 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $37.58 | 2019-2020 | |
| Pfizer INC. | $25.05 | 2019 | |
| Glaxosmithkline, LLC. | $23.75 | 2019 | |
| Fisher & Paykel Healthcare INC | $22.20 | 2024 | Fisher & Paykel Healthcare |
| Ge Healthcare | $18.28 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maneka Kaul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.